04/17/2025 3:39 PM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2025 7:37 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/18/2025 3:28 PM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2025 7:13 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2025 6:34 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/24/2025 3:53 PM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/24/2025 6:01 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
02/21/2025 6:07 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2025 6:00 AM | Kluge Andreas (Filed by) Telix Pharmaceuticals (Subject) Telix Pharmaceuticals Ltd (Subject)
| Form SCHEDULE 13G | |
02/14/2025 6:00 AM | Behrenbruch Christian (Filed by) Telix Pharmaceuticals (Subject) Telix Pharmaceuticals Ltd (Subject)
| Form SCHEDULE 13G | |
02/13/2025 7:09 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for TLPPF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
01/31/2025 6:19 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/27/2025 3:40 PM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025 5:49 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024 3:05 PM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024 5:16 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/19/2024 6:30 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024 6:00 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024 11:15 PM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form EFFECT | |
11/12/2024 4:00 PM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form SEC STAFF ACTION | |
11/12/2024 12:33 PM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form CERT | |
10/29/2024 6:03 PM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 20FR12B/A | |
10/17/2024 4:23 PM | JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by) Telix Pharmaceuticals (Subject) Telix Pharmaceuticals Ltd (Subject)
| Form F-6 Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts | |
10/17/2024 3:05 PM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form 20FR12B | |
06/14/2024 11:19 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form RW | |
06/14/2024 7:12 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form RW | |
06/05/2024 5:43 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form F-1/A | |
05/30/2024 5:31 AM | JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by) Telix Pharmaceuticals (Subject) Telix Pharmaceuticals Ltd (Subject)
| Form F-6 Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts | |
05/17/2024 5:24 AM | Telix Pharmaceuticals (Filer) Telix Pharmaceuticals Ltd (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |